Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2009;35(2):63-7.
doi: 10.1080/00952990802585380.

Brief vs. extended buprenorphine detoxification in a community treatment program: engagement and short-term outcomes

Elizabeth C Katz  1 , Robert P Schwartz, Stuart King, David A Highfield, Kevin E O'Grady, Timothy Billings, Devang Gandhi, Eric Weintraub, David Glovinsky, Wardell Barksdale, Barry S Brown
Affiliations
Comparative Study

Brief vs. extended buprenorphine detoxification in a community treatment program: engagement and short-term outcomes

Elizabeth C Katz et al. Am J Drug Alcohol Abuse. 2009.

Abstract

Background: Despite evidence supporting the efficacy of buprenorphine relative to established detoxification agents such as clonidine, little research has examined: 1) how best to implement buprenorphine detoxification in outpatient settings; and 2) whether extending the length of buprenorphine detoxification improves treatment engagement and outcomes.

Objectives: The current study examined the impact on 1) successful detoxification completion; 2) transition to longer-term treatment; and 3) treatment engagement of two different length opioid detoxifications using buprenorphine.

Methods: The study compared data obtained from two consecutive studies of early treatment engagement strategies. In one study (n = 364), opioid-addicted participants entered treatment through a Brief (5-day) buprenorphine detoxification. In the other study (n = 146), participants entered treatment through an Extended (i.e., 30-day) buprenorphine detoxification.

Results: Results indicated a greater likelihood of successful completion and of transition among participants who received the Extended as compared to the Brief detoxification. Extended detoxification participants attended more counseling sessions and submitted fewer drug-positive urine specimens during the first 30 days of treatment, inclusive of detoxification, than did Brief detoxification participants.

Conclusions: Results demonstrate that longer periods of detoxification improve participant engagement in treatment and early treatment outcomes.

Scientific significance: Current findings demonstrate the feasibility of implementing an extended buprenorphine detoxification within a community-based treatment clinic.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

All authors declare that they have no conflicts of interest.

References

    1. Substance Abuse and Mental Health Services Administration Office of Applied Studies. DASIS Series: S-40, DHHS Publication No. (SMA) 08-4313. Rockville, MD: 2008. Treatment Episode Data Set (TEDS) Highlights – 2006. National Admissions to Substance Abuse Treatment Services. Table 4.
    1. Becker A, Strain E, Bigelow G, Stitzer M, Johnson R. Gradual Dose Taper Following Chronic buprenorphine. The American Journal on Addictions. 2001;10:111–121. - PubMed
    1. Greenwald M, Schuh K, Stine S. Transferring Methadone-maintained outpatients to the buprenorphine sublingual tablet: A preliminary study. The American Journal on Addictions. 2003;12:365–374. - PubMed
    1. Bell J, Byron G, Gibson A, Morris A. A pilot study of buprenorphine-naloxone combination tablet (Suboxone®) in treatment of opioid dependence. Drug and Alcohol Review. 2004;23:311–317. - PubMed
    1. Collins E, Kleber H, Whittington R, Heitler N. Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: A randomized trial. The Journal of the American Medical Association. 2005;294:903–913. - PubMed

Publication types

MeSH terms